1. Home
  2. GVA vs ICUI Comparison

GVA vs ICUI Comparison

Compare GVA & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GVA
  • ICUI
  • Stock Information
  • Founded
  • GVA 1922
  • ICUI 1984
  • Country
  • GVA United States
  • ICUI United States
  • Employees
  • GVA N/A
  • ICUI N/A
  • Industry
  • GVA Military/Government/Technical
  • ICUI Medical/Dental Instruments
  • Sector
  • GVA Industrials
  • ICUI Health Care
  • Exchange
  • GVA Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • GVA 3.3B
  • ICUI 3.6B
  • IPO Year
  • GVA 1990
  • ICUI 1992
  • Fundamental
  • Price
  • GVA $75.18
  • ICUI $139.11
  • Analyst Decision
  • GVA Strong Sell
  • ICUI Buy
  • Analyst Count
  • GVA 1
  • ICUI 4
  • Target Price
  • GVA $70.00
  • ICUI $199.67
  • AVG Volume (30 Days)
  • GVA 834.1K
  • ICUI 294.5K
  • Earning Date
  • GVA 05-01-2025
  • ICUI 05-06-2025
  • Dividend Yield
  • GVA 0.69%
  • ICUI N/A
  • EPS Growth
  • GVA 169.33
  • ICUI N/A
  • EPS
  • GVA 2.62
  • ICUI N/A
  • Revenue
  • GVA $4,007,574,000.00
  • ICUI $2,382,046,000.00
  • Revenue This Year
  • GVA $8.05
  • ICUI $0.21
  • Revenue Next Year
  • GVA $6.10
  • ICUI $2.47
  • P/E Ratio
  • GVA $28.65
  • ICUI N/A
  • Revenue Growth
  • GVA 14.20
  • ICUI 5.44
  • 52 Week Low
  • GVA $52.99
  • ICUI $93.36
  • 52 Week High
  • GVA $105.20
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • GVA 41.17
  • ICUI 40.91
  • Support Level
  • GVA $74.35
  • ICUI $142.83
  • Resistance Level
  • GVA $79.65
  • ICUI $152.06
  • Average True Range (ATR)
  • GVA 2.03
  • ICUI 5.75
  • MACD
  • GVA 0.63
  • ICUI 0.51
  • Stochastic Oscillator
  • GVA 48.50
  • ICUI 52.59

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: